Gazeau N, Beauvais D, Tilmont R, Srour M, et al. Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time? Leukemia 2025 Apr 24. doi: 10.1038/s41375-025-02605.
PMID: 40275069